• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Aug 1, 2019
Emerging Company Profile

NeoPhore: Driving neoantigen production via DNA mismatch repair

NeoPhore is making tumor cells more visible to the immune system by triggering neoantigen production
Read More
BioCentury | Apr 13, 2018
Targets & Mechanisms

Meeting the burden

New developments in TMB, synthetic lethality, oncolytic viruses & more at AACR18
Read More
BioCentury | Dec 8, 2017
Targets & Mechanisms

Pathways emerging from ASH

An analysis of emerging targets at ASH by mechanism
Read More
BioCentury | Mar 25, 2015
Politics & Policy

CMS to emphasize clinical utility of prognostic cancer tests

Read More
BioCentury | Jan 27, 2015
Politics & Policy

CMS to discuss prognostic tests for cancer

Read More
BioCentury | Mar 25, 2010
Distillery Therapeutics

Indication: Cancer

Read More
BioCentury | Aug 27, 2009
Distillery Therapeutics

Indication: Cancer

Read More
Items per page:
1 - 7 of 7